JPRN-UMIN000005494招募中未知
Aprepitant for nausea, vomiting with the TC therapy of the gynecology cancer patient or the DC therapy, fosaprepitant, granisetron, protective efficacy of the dexamethasone combination therapy. - TC, aprepitant for nausea, vomiting with the DC therapy, protective efficacy of fosaprepitant.
agasaki University (graduate school) department of Obstetrics and Gynecology0 个研究点目标入组 140 人开始时间: 2011年4月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1) Patient has a serious hepatic insufficiency or renal failure 2) Patient has nausea or vomiting within 24 hours prior to chemotherapy 3) Patient has been treated with antiemetic agents within 48 hours prior to chemotherapy 4) Patient has any illness (e.g. central nervous system tumors, gastrointestinal obstruction, active peptic ulcer, brain metastasis) caused nausea or vomiting except for chemotherapy-induced nausea and vomiting 5) Patient is scheduled to receive radiation therapy to the abdomen 6) Patient has the collateral symptom that the dosage of the dexamethasone is impossible for four days 7) Patient has received Pimozide 8) Patient is judged inappropriate by the investigator as subject for this study
研究者
相似试验
尚未招募
1 期
The efficacy of electrical stimulation to control the symptoms of nausea and vomiting in pregnant women.Hyperemesis gravidarumRBR-9z5t9qniversidade Federal de Alfenas
招募中
不适用
Effect of aprepitant for nausea and vomiting during Paclitaxel + Carboplatin (TC) therapyJPRN-UMIN000012500Osaka Medical College Department of Obstetrics and Gynecology50
撤回
不适用
The Nausea Care App in patients receiving chemotherapy: A Randomized Controlled TrialPatienten die chemotherapie krijgen voor mamma-, ovarium-, hodgkin-, non-hodgkinNauseavomitingNL-OMON43482Oncologie206
已完成
4 期
Droperidol vs Ondansetron in Nausea Treatment in the Emergency Department (DONuT)ACTRN12619001205123A/Prof Gabriel T Lau180
进行中（未招募）
不适用
Treatment of Patients Suffering from Nausea/Vomiting with Dronabinol (tetrahydrocannabinol)Comparsion of three dosages versus standard therapy in a cross-over desigausea/Vomiting of patients receiving chemotherapyMedDRA version: 9.1Level: LLTClassification code 10036899Term: Prophylaxis against chemotherapy induced vomitingMedDRA version: 9.1Level: LLTClassification code 10056989Term: Nausea post chemotherapyEUCTR2007-000444-27-ATBionorica research GmbH30